Global Cell & Gene Therapy Drug Delivery Devices Market Comprehensive Analysis and Forecast 2023 to 2028

May 19, 2025 - 18:07
 0

Global Cell & Gene Therapy Drug Delivery Devices Market Overview: 2023-2028

Base Year: 2022

Historical Years:  2018-21

Forecast Years: 2023-2028

The Global Cell & Gene Therapy Drug Delivery Devices Market is anticipated to grow at a CAGR of around 14% during the forecast period, i.e., 2023-28, says MarkNtel Advisors. The Global Cell & Gene Therapy Drug Delivery Devices Market is going through significant growth due to multiple drivers like technological advancements and, of course, increasing healthcare needs. The increase in road accidents throughout the country creates a greater demand for X-rays.

Markntel Advisor’s Global Cell & Gene Therapy Drug Delivery Devices Market Insights report provides the current and forecast market analysis, individual leading companies' market shares, challenges, Global Cell & Gene Therapy Drug Delivery Devices Market drivers, barriers, Global Cell & Gene Therapy Drug Delivery Devices Market Trends, and Key Players in Global Cell & Gene Therapy Drug Delivery Devices Market.

Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report - This paragraph to be added on Request sample Line and after then add   LINK OF SAMPLE

Global Cell & Gene Therapy Drug Delivery Devices Market Dynamics: 2023-2028

Market Dynamics

Key Drivers

·         The factors that are projected to drive the market in the coming years include the following:

·         Substantial investments in R&D, particularly across the US, for the development of new & improved cell & gene therapies

·         Mounting prevalence of genetic disorders & chronic diseases

·         An increasing number of FDA approvals for cell & gene therapies & their clinical trials.

Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

Global Cell & Gene Therapy Drug Delivery Devices Market (2023-30): Segmentation Outlook

The market report has segmented the market into the following categories:

By Product Type

Sub-retinal Injection Cannula

Extension Tube

Intravenous Catheter

Sterile Insulin Syringe

Size 1.0 ML, 31-Gauge Needle

Size 0.5 ML, 22-Gauge Needle

 Pre-Filled Syringe

Size 1.0 ML, 22-26 Gauge Needle

Size 4.0 ML, 22-26 Gauge Needle

 Infusion Bags

Infusion Bags (Size 10 ML to 50 ML)

Infusion Bags (Size 68 ML)

Infusion Bags (Size 60 ML)

Infusion Bags (Size Up to 65 ML)

By Technology

Microchip Technology

Nano-Technology

Lipid Nanoparticles

By Commercialized Drugs

Luxturna

Kymriah

Yescarta

Zolgensma

Provenge

Strimvelis

By End-User

Pharmaceuticals & Biotechnology Company

Academic & Research Institute

Hospitals & Clinics

By Region

North America

South America

Europe

Middle East & Africa

Asia-Pacific.

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

Top Companies Operating in the Global Cell & Gene Therapy Drug Delivery Devices Market:

Amgen Inc., Bausch & Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio Inc., Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.), Dendreon Pharmaceuticals LLC, Helixmith Co. Ltd (ViroMed Co., Ltd), Human Stem Cells Institute, Kite Pharma Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., Pfizer Inc., Renova Therapeutics, Spark Therapeutics Inc., uniQure N.V., Vericel Corporation.

Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India